1143 A phase III study of the efficacy and safety of adjuvant atezolizumab (anti-PDL1) vs observation in patients with muscle-invasive urothelial carcinoma of the bladder (IMvigor 010)
Castellano, D., Albers, P., Gschwend, J.E., Culine, S., Bullmunt, J., Hussain, M., Shen, X., Nelson, B., Powles, T.Volume:
15
Language:
english
Journal:
European Urology Supplements
DOI:
10.1016/s1569-9056(16)61144-2
Date:
March, 2016
File:
PDF, 201 KB
english, 2016
File converter
More search results
More benefits 
